Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 19, 2021

SELL
$14.21 - $17.65 $2,842 - $3,529
-200 Closed
0 $0
Q1 2021

Apr 20, 2021

SELL
$7.37 - $13.61 $1,474 - $2,722
-200 Reduced 50.0%
200 $2,000
Q4 2020

Jan 28, 2021

BUY
$3.37 - $8.61 $1,348 - $3,444
400 New
400 $3,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.